• Je něco špatně v tomto záznamu ?

USP15 regulates radiation-induced DNA damage and intestinal injury through K48-linked deubiquitination and stabilisation of ATM

R. Zhu, M. Li, D. Wang, C. Liu, L. Xie, Y. Yang, X. Gu, K. Zhao, Y. Tian, S. Cai

. 2024 ; 30 (1) : 205. [pub] 20241109

Jazyk angličtina Země Anglie, Velká Británie

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc25003488

Grantová podpora
Szlcyxzx202103 Suzhou Medical Center
JSDW202236 Key Medical Discipline of Jiangsu
GSWS2020028 Research project of medical talent of Suzhou
GSWS2021025 Research project of medical talent of Suzhou
M2021081 Science Foundation of Jiangsu Health Commission
ML12300723 Young Physician Scientist Project at Suzhou Medical College of Soochow University
202310285167Y Jiangsu Province College Student Innovation and Entrepreneurship Training Program Project
XKTJ-RC202407 Young Talent Support Project of The Second Affiliated Hospital of Soochow University
GZK1202405 Project of State Key Laboratory of Radiation Medicine and Protection, Soochow University
Shang Cai Medical talent of Suzhou

BACKGROUND: Radiation-induced intestinal injury (RIII) interrupts the scheduled processes of abdominal and pelvic radiotherapy (RT) and compromises the quality of life of cancer survivors. However, the specific regulators and mechanisms underlying the effects of RIII remain unknown. The biological effects of RT are caused primarily by DNA damage, and ataxia telangiectasia mutated (ATM) is a core protein of the DNA damage response (DDR). However, whether ATM is regulated by deubiquitination signaling remains unclear. METHODS: We established animal and cellular models of RIII. The effects of ubiquitin-specific protease 15 (USP15) on DNA damage and radion-induced intestinal injury were evaluated. Mass spectrometry analysis, truncation tests, and immunoprecipitation were used to identify USP15 as a binding partner of ATM and to investigate the ubiquitination of ATM. Finally, the relationship between the USP15/ATM axes was further determined via subsequent experiments. RESULTS: In this study, we identified the deubiquitylating enzyme USP15 as a regulator of DNA damage and the pathological progression of RIII. Irradiation upregulates the expression of USP15, whereas pharmacological inhibition of USP15 exacerbates radiation-induced DNA damage and RIII both in vivo and in vitro. Mechanistically, USP15 interacts with, deubiquitinates, and stabilises ATM via K48-linked deubiquitination. Notably, ATM overexpression blocks the effect of USP15 genetic inhibition on DNA damage and RIII progression. CONCLUSIONS: These findings describe ATM as a novel deubiquitination target of USP15 upon radiation-induced DNA damage and intestinal injury, and provides experimental support for USP15/ATM axis as a potential target for developing strategies that mitigate RIII.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc25003488
003      
CZ-PrNML
005      
20250206104355.0
007      
ta
008      
250121s2024 enk f 000 0|eng||
009      
AR
024    7_
$a 10.1186/s10020-024-00984-8 $2 doi
035    __
$a (PubMed)39522000
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a enk
100    1_
$a Zhu, Ruiqiu $u Suzhou Key Laboratory for Radiation Oncology, Department of Radiotherapy and Oncology, The Second Affiliated Hospital of Soochow University, Suzhou, 215004, China
245    10
$a USP15 regulates radiation-induced DNA damage and intestinal injury through K48-linked deubiquitination and stabilisation of ATM / $c R. Zhu, M. Li, D. Wang, C. Liu, L. Xie, Y. Yang, X. Gu, K. Zhao, Y. Tian, S. Cai
520    9_
$a BACKGROUND: Radiation-induced intestinal injury (RIII) interrupts the scheduled processes of abdominal and pelvic radiotherapy (RT) and compromises the quality of life of cancer survivors. However, the specific regulators and mechanisms underlying the effects of RIII remain unknown. The biological effects of RT are caused primarily by DNA damage, and ataxia telangiectasia mutated (ATM) is a core protein of the DNA damage response (DDR). However, whether ATM is regulated by deubiquitination signaling remains unclear. METHODS: We established animal and cellular models of RIII. The effects of ubiquitin-specific protease 15 (USP15) on DNA damage and radion-induced intestinal injury were evaluated. Mass spectrometry analysis, truncation tests, and immunoprecipitation were used to identify USP15 as a binding partner of ATM and to investigate the ubiquitination of ATM. Finally, the relationship between the USP15/ATM axes was further determined via subsequent experiments. RESULTS: In this study, we identified the deubiquitylating enzyme USP15 as a regulator of DNA damage and the pathological progression of RIII. Irradiation upregulates the expression of USP15, whereas pharmacological inhibition of USP15 exacerbates radiation-induced DNA damage and RIII both in vivo and in vitro. Mechanistically, USP15 interacts with, deubiquitinates, and stabilises ATM via K48-linked deubiquitination. Notably, ATM overexpression blocks the effect of USP15 genetic inhibition on DNA damage and RIII progression. CONCLUSIONS: These findings describe ATM as a novel deubiquitination target of USP15 upon radiation-induced DNA damage and intestinal injury, and provides experimental support for USP15/ATM axis as a potential target for developing strategies that mitigate RIII.
650    12
$a ATM protein $x metabolismus $x genetika $7 D064007
650    _2
$a zvířata $7 D000818
650    12
$a poškození DNA $7 D004249
650    12
$a ubikvitinace $7 D054875
650    _2
$a lidé $7 D006801
650    12
$a specifické proteázy ubikvitinu $x metabolismus $x genetika $7 D064570
650    _2
$a myši $7 D051379
650    _2
$a střeva $x účinky záření $x patologie $7 D007422
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a radiační poranění $x metabolismus $x genetika $7 D011832
650    _2
$a modely nemocí na zvířatech $7 D004195
655    _2
$a časopisecké články $7 D016428
700    1_
$a Li, Mingyue $u Suzhou Key Laboratory for Radiation Oncology, Department of Radiotherapy and Oncology, The Second Affiliated Hospital of Soochow University, Suzhou, 215004, China
700    1_
$a Wang, Difan $u Suzhou Medical College of Soochow University, Suzhou, 215000, China
700    1_
$a Liu, Chengzhi $u Suzhou Key Laboratory for Radiation Oncology, Department of Radiotherapy and Oncology, The Second Affiliated Hospital of Soochow University, Suzhou, 215004, China
700    1_
$a Xie, Liwei $u Suzhou Key Laboratory for Radiation Oncology, Department of Radiotherapy and Oncology, The Second Affiliated Hospital of Soochow University, Suzhou, 215004, China
700    1_
$a Yang, Yinyin $u Suzhou Key Laboratory for Radiation Oncology, Department of Radiotherapy and Oncology, The Second Affiliated Hospital of Soochow University, Suzhou, 215004, China
700    1_
$a Gu, Xuhao $u Suzhou Key Laboratory for Radiation Oncology, Department of Radiotherapy and Oncology, The Second Affiliated Hospital of Soochow University, Suzhou, 215004, China
700    1_
$a Zhao, Kui $u Department of Gastrointestinal Surgery, The Second Affiliated Hospital of Soochow University, Suzhou, 215004, China. zhaokui2@126.com
700    1_
$a Tian, Ye $u Suzhou Key Laboratory for Radiation Oncology, Department of Radiotherapy and Oncology, The Second Affiliated Hospital of Soochow University, Suzhou, 215004, China. dryetian@126.com
700    1_
$a Cai, Shang $u Suzhou Key Laboratory for Radiation Oncology, Department of Radiotherapy and Oncology, The Second Affiliated Hospital of Soochow University, Suzhou, 215004, China. cbibbys@163.com $u PRaG Therapy Center, Center for Cancer Diagnosis and Treatment, The Second Affiliated Hospital of Soochow University, Suzhou, 215004, China. cbibbys@163.com
773    0_
$w MED00003396 $t Molecular medicine (Cambridge, Mass. Print) $x 1528-3658 $g Roč. 30, č. 1 (2024), s. 205
856    41
$u https://pubmed.ncbi.nlm.nih.gov/39522000 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y - $z 0
990    __
$a 20250121 $b ABA008
991    __
$a 20250206104351 $b ABA008
999    __
$a ok $b bmc $g 2263324 $s 1239495
BAS    __
$a 3
BAS    __
$a PreBMC-MEDLINE
BMC    __
$a 2024 $b 30 $c 1 $d 205 $e 20241109 $i 1528-3658 $m Molecular medicine (Cambridge, Mass. Print) $n Mol Med $x MED00003396
GRA    __
$a Szlcyxzx202103 $p Suzhou Medical Center
GRA    __
$a JSDW202236 $p Key Medical Discipline of Jiangsu
GRA    __
$a GSWS2020028 $p Research project of medical talent of Suzhou
GRA    __
$a GSWS2021025 $p Research project of medical talent of Suzhou
GRA    __
$a M2021081 $p Science Foundation of Jiangsu Health Commission
GRA    __
$a ML12300723 $p Young Physician Scientist Project at Suzhou Medical College of Soochow University
GRA    __
$a 202310285167Y $p Jiangsu Province College Student Innovation and Entrepreneurship Training Program Project
GRA    __
$a XKTJ-RC202407 $p Young Talent Support Project of The Second Affiliated Hospital of Soochow University
GRA    __
$a GZK1202405 $p Project of State Key Laboratory of Radiation Medicine and Protection, Soochow University
GRA    __
$a Shang Cai $p Medical talent of Suzhou
LZP    __
$a Pubmed-20250121

Najít záznam

Citační ukazatele

Možnosti archivace